Get App Open
In App
Credit Cards
Open App
you are here:
Success
Alert
Please select a Day.
Info

Jagsonpal Pharmaceuticals Ltd.

Sector : Healthcare | Industry : Pharmaceuticals & Drugs

72/100
219.64
-1.89 (-0.85%)

As on 23 Oct, 2025 | 02:27

Open Trading A/c
Day Range
219.00
223.88
L H
52 Week Range
176.30
328.04
L H
Volume
23,493
*
i
Bid / Ask
/
72/100
219.90
-1.95 (-0.88%)

As on 23 Oct, 2025 | 02:27

Open Trading A/c
Day Range
219.90
224.95
L H
52 Week Range
176.04
328.02
L H
Volume
1,289
*
i
Bid / Ask
/
NSE
MC Essentials
82% Pass
MC Technicals
i
This represents current trend.Click here for disclaimer.
MC Insights

Superior Financial Strength, High Growth Trend Stock at Reasonable Valuations

Financials
    Ownerships
      Industry Comparison
        Others
          Open 222.50
          Previous Close 221.53
          Volume 23,493.00
          Value (Lacs) 51.60
            VWAP 220.72
          Beta
          Mkt Cap (Rs. Cr.) 1,466
          High 223.88
          Low 219.00
          UC Limit 265.83
          LC Limit 177.22
          52 Week High 328.04
          52 Week Low 176.30
          Face Value 2.00
          All Time High 328.04
          All Time Low 2.40
          20D Avg Volume 83,330
          20D Avg Delivery(%) 48.53
          Book Value Per Share --
          Dividend Yield 1.14
          TTM EPS See historical trend 0.00 (+149.17% YoY)
          TTM PE See historical trend -- (Low PE)
          P/B See historical trend 0.00 (Low P/B)
          Sector PE 40.05

          Advanced Chart

          Click here to expand

          *Delayed by 20 seconds.

          Forecast                                                

          Earnings Forecast

          Actuals Estimates
          ANNUALLY 
          (Rs.) 

          Valuations

          Consensus Recommendations

          • Buy
          • Outperform
          • Hold
          • Underperform
          • Sell

          Hits/Misses

          QUARTERLY (Rs.)
          # of Beats
          # of Misses
          # of Inline
          # of Beats
          # of Misses
          # of Inline
          # of Beats
          # of Misses
          # of Inline

          MC Insights

          Stock Score

          72/100
          Superior Financial Strength, High Growth Trend Stock at Reasonable Valuations

          Get detailed analysis with Moneycontrol Stock Insights.

          Get detailed analysis with Moneycontrol Stock Insights.

          Price
          • 33.04% away from 52 week high

          Financials
          Piotroski Score
          i

          indicates

          Industry Comparison
          • Market Cap - Above Median

          Shareholding Pattern
          • Promoters decreased holding from 67.65% to 67.54% in Sep 2025 qtr.

          MC Technicals

          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Pivot levels

          R1 - - Pivot
          - -
          S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Moving Averages
          Days
          5 - -
          10 - -
          20 - -
          50 - -
          100 - -
          200 - -
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Pivot levels

          R1 - - Pivot
          - -
          S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Moving Averages
          Days
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Pivot levels

          R1 - - Pivot
          - -
          S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Moving Averages
          Days

          Price and Volume

          Price Performance
          1 Week
          --%
          1 Month
          --%
          3 Months
          --%
          YTD
          --%
          1 Year
          --%
          3 Years
          --%
          Volume Analysis
          • Volume
          • Delivery

          SEASONALITY ANALYSIS

          12 out of 16 years Jagsonpal Pharmaceuticals has given positive returns in October.

          Month Max. Positive Change(%) Avg. Positive Change(%) Max. Negative Change(%) Avg. Negative Change(%) Average Change(%)
          October 31.75% (2017) 12.15% -18.27% (2009) -11.28% 6.29%

          Forum

          Community Sentiments

          • 100% BUY
          • 0% SELL
          • 0% HOLD
          100%
          of moneycontrol users recommend buying JagsonpalPharma

          What's your call on JagsonpalPharma today?

          Read 0 investor views

          BUY SELL HOLD

          Broker Research

          No Data For Broker Research.

          Deals

          13 Sep, 2024

          Infinity Portfolio Holdings

          Qty 2200000 Price 400 % Traded 8.09
          13 Sep, 2024

          Infinity Holdings

          Qty 2200000 Price 400 % Traded 8.09

          *Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.

          28 Jul, 2025

          Graviton Research Capital Llp

          Qty 498300 Price 293.68 % Traded 0.75
          28 Jul, 2025

          Graviton Research Capital Llp

          Qty 498300 Price 294.1 % Traded 0.75
          28 Jul, 2025

          Hrti Private Limited

          Qty 350647 Price 293.56 % Traded 0.53
          28 Jul, 2025

          Hrti Private Limited

          Qty 343628 Price 293.5 % Traded 0.52
          29 Nov, 2024

          Ankita Vishal Shah

          Qty 249425 Price 775.17 % Traded 0.95
          29 Nov, 2024

          Ankita Vishal Shah

          Qty 154425 Price 779.54 % Traded 0.59
          13 Sep, 2024

          Infinity Portfolio Holdings

          Qty 2200000 Price 400 % Traded 8.09
          13 Sep, 2024

          Infinity Holdings

          Qty 2200000 Price 400 % Traded 8.09

          *A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange.

          Financials

          • Revenue
          • Net Profit
          • EPS
          • BVPS
          • ROE
          • Debt to Equity
          • Revenue
          • Net Profit
          • EPS
          • BVPS
          • ROE
          • Debt to Equity

          Shareholding

          PEERS

          Company Name Price % Chg MCap(Cr) TTM PE P/B ROE(%) 1 Yr Perform(%) Net Profit(Rs.) Net Sales(Rs.) Debt to Equity
          JagsonpalPharma 219.64 -0.85 1,465.54 24.08 7.43 23.11 12.68 55 268 0.00
          Sun Pharma 1,690.70 0.01 405,655.56 39.11 5.87 15.13 -8.08 10,980 52,578 0.03
          Divis Labs 6,601.00 0.21 175,235.81 75.99 12.78 14.63 15.25 2,191 9,360 0.00
          Cipla 1,646.40 -1.03 132,990.54 24.66 4.69 16.90 8.05 5,291 27,547 0.00
          Torrent Pharma 3,623.90 0.92 122,649.24 61.27 16.34 25.17 6.82 1,911 11,516 0.40

          About the Company

          Jagsonpal Pharmaceuticals Limited is engaged in developing and manufacturing active pharmaceutical ingredients (APIs) and formulations. The Company has research and development, manufacturing, marketing and distribution facilities. The Companys plant is located in Uttarakhand. The Companys brands include Lycored, Maintane, Metadec, Metabol, Doxypal DR, Parvon and Indocap SR. Its API products include Allylestrenol, Dextropropoxyphene Hydrochloride, Dextropropoxyphene Napsylate, Disulfiram, Thiopental Sodium, Thiopental Acid and Tolnaftate. The Company operates in Russia, Brazil, the United States, Ukraine, Sri Lanka, Cameroon, Thailand, Argentina, Germany, Switzerland, Korea, Egypt and Vietnam. It was founded in 1964..The company also engagged in the business of Pharmaceutical, Profit Before Tax, Net Profit After Tax.
          {"success":1,"data":{"address":{"address1":"Innov8 3rd Floor,","address2":",Plot No. 211, Okhla Phase \u2013 III,","city":"New Delhi","state":"Delhi","pincode":"110020","telephone1":"011-46181100","telephone2":"011-46119900","fax1":"011-26498341","fax2":"","email":"cs@jagsonpal.com","web":"http:\/\/www.jagsonpal.com"},"management":[{"name":"Rajpal Singh Kochhar","designation":"Chairman Emeritus"},{"name":"Harsha Raghavan","designation":"Chairman & Non-Exe.Director"},{"name":"Manish Gupta","designation":"Managing Director"},{"name":"Prithipal Singh Kochhar","designation":"Non Executive Director"},{"name":"Debasis Bikash Nandy","designation":"Independent Director"}],"registrars":{"name":"MCS Share Transfer Agent Ltd.","address1":"179-180, DSIDC Shed, 3rd Floor, Okhla Industrial A","address2":"","address3":"","address4":"","telephone":"011-41406149, 41406150, 41406151","fax":"011-41709881","email":"helpdeskdelhi@mcsregistrars.com","internet":"www.mcsregistrars.com","city":"New Delhi","state":"Delhi","pincode":"110020"},"listing":[{"name":"BSE 100","value":"No"},{"name":"BSE 200","value":"No"},{"name":"SENSEX","value":"No"},{"name":"CNX MIDCAP 200","value":"No"},{"name":"NIFTY 50","value":"No"},{"name":"BSE 500","value":"No"},{"name":"Nifty 200","value":"No"}],"details":{"bseId":"507789","nseId":"JAGSNPHARM","series":"EQ","isinid":"INE048B01035"}}}
          • Registered Office

            • Address

              Innov8 3rd Floor,,,Plot No. 211, Okhla Phase – III,

            • City

              New Delhi

            • State

              Delhi

            • Pin Code

              110020

            • Tel. No.

              011-46181100

            • Fax No.

              011-26498341

            • Email

              cs@jagsonpal.com

            • Internet

              http://www.jagsonpal.com

          • Registrars

          • Management

            • Rajpal Singh Kochhar

              Chairman Emeritus

            • Harsha Raghavan

              Chairman & Non-Exe.Director

            • Manish Gupta

              Managing Director

            • Prithipal Singh Kochhar

              Non Executive Director

            • Debasis Bikash Nandy

              Independent Director

          • Included In

            • BSE 100

              No

            • BSE 200

              No

            • SENSEX

              No

            • CNX MIDCAP 200

              No

            • NIFTY 50

              No

            • BSE 500

              No

            • Nifty 200

              No

          • Details

            • BSE:

              507789

            • NSE:

              JAGSNPHARM

            • Series

              EQ

            • ISIN

              INE048B01035